Dr. Michael Starr is a Member of the MUHC’s Rheumatology Division. Formerly head of training in rheumatology at McGill, he continues to teach in continuing education programs in Montreal and elsewhere in Canada. He has been involved in many therapeutic clinical trials regarding inflammatory arthritis, has published several articles and books, and co-authored a book for the general public on the role of nutrition in the treatment of arthritis. In addition, Dr. Starr is the Rheumatology Editor for the Canadian Journal of Diagnosis and Regional Director of the Patient-Partner in Arthritis program in Montreal.
9:15 - 10:15
11:00 - 12:00
Rheumatoid Arthritis (RA) is one of the most common forms of inflammatory arthritis—it is reported to afflict about 1% of the population. This often affects people at younger ages, and if not treated early and effectively can lead to chronic pain in joints, deformities, and significant disability. Great strides have been made in our understanding of the disease and in research and development of new targeted therapies for this condition. We are seeing a major improvement in outcomes for patients with the new treatments that are now available, and the field of rheumatology is changing rapidly with exciting new developments every year. Although a true cure may not yet be available, there is hope, and we are coming ever closer.
This conference is also offered on the Web.